limits of diagnostics for presymptomatic diagnosis and preemptive treatment of some diseases. Nanobiotechnology techniques provide an analysis of DNA and protein and could dramatically improve speed, accuracy and sensitivity compared to conventional mo-lecular diagnostic methods [5]. Nanobiotechnology-based approaches can provide more precise measure-ments and insight into nanoscale inherent functional components of living cells. Nanobiotechnology facilitates point-of-care diagnosis and the integration of diagnostics with therapeutics, thus advancing the development of personalized medicine. Molecular imaging requires an accumulation of con-trast agent in the target site, often most efficiently achieved by steering nanoparticles containing contrast agent to
No takes yet. Share an insight, caveat, or question.
KK Jain (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: